On August 9 the U.S
In a watershed moment for psychedelics in Europe, the European Medicines Agency (EMA) held a workshop from 16 to 17 April to discuss regulatory guidelines for...
Following several transformative milestones in psychedelics, coupled with a surge in biotech investment, 2024 is set to see a profound shift for the sector as investors...
A new company specialising in psychedelic medicine – mychedelica – is offering a comprehensive suite of services to support the advancement of this transformative field.
UK charity Transform Drug Policy Foundation has published a new book ‘How to Regulate Psychedelics: A Practical Guide’ that sets out how psychedelics can be legalised...
California could decriminalise naturally occurring psychedelics and create a framework for their therapeutic use under a new bill.
As their 300-gram MDMA shipment got to the border, PharmAla Biotech found themselves in a sticky situation.
For the first time, the U.S.
Psychedelics stand at a pivotal crossroads in mental health, offering the prospect of novel therapeutic avenues to address multiple mental conditions, from treatment-resistant depression to post-traumatic...
With a rise in clinical research and trials into the use of psychedelic therapies for mental health, and with a number of countries changing regulations around...
